title: Olopatadine hydrochloride decreases tissue interleukin-31 levels in an atopic dermatitis mouse model.
authors.affiliation: Department of Dermatology, Osaka Graduate School of Medicine, Osaka 565-0871, Japan. h-murota@derma.med.osaka-u.ac.jp.
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Murota
authors.forename: Mostafa Abd
authors.initials: MA
authors.lastname: El-latif
authors.forename: Tadafumi
authors.initials: T
authors.lastname: Tamura
authors.forename: Ichiro
authors.initials: I
authors.lastname: Katayama
mesh_terms: D000818:Animals; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D003876:Dermatitis, Atopic / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism*; D003990:Dibenzoxepins / Q000627:therapeutic use*; D004195:Disease Models, Animal; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007378:Interleukins / Q000378:metabolism*; D051379:Mice; D000069605:Olopatadine Hydrochloride; D011537:Pruritus / Q000209:etiology / Q000378:metabolism; D016559:Tacrolimus / Q000627:therapeutic use
chemical_list: D018926:Anti-Allergic Agents; D003990:Dibenzoxepins; D007166:Immunosuppressive Agents; D007378:Interleukins; C502588:interleukin-31, mouse; D000069605:Olopatadine Hydrochloride; D016559:Tacrolimus